Document is current
Any future updates will be listed below
-
Authors
Demirci, Ilke
Larsson, Anton J. M.
Chen, Xinsong
Hartman, Johan
Sandberg, Rickard
Frisén, Jonas http://orcid.org/0000-0001-5819-458X
-
Funding
Funding for this research was provided by:
Vetenskapsrådet
Cancerfonden
Knut och Alice Wallenbergs Stiftelse
Stiftelsen för Strategisk Forskning
Göran Gustafssons Stiftelse för Naturvetenskaplig och Medicinsk Forskning
Karolinska Institute
- License Information
-
More Information
Article History
Received: 5 July 2023
Accepted: 30 July 2024
First Online: 9 August 2024
Declarations
:
: The breast tumor samples were collected with approval from Etikprövningsnämnden in Stockholm 2016/957–31, amendment 2017/742- 32, 2021–00795, and 2022–05245-02.Informed consent was obtained from the participants, and the study was conducted in accordance with the principles of the Declaration of Helsinki.
: R.S. is an inventor on a patent for Smart-seq3 that is licensed to Takara Bio USA. J.F. is a scientific consultant for 10x Genomics. The remaining authors declare no competing interests.
